Home  »  Companies   »  Avenue Therapeutics Inc. (ATXI) Volatility At 8.60...

Avenue Therapeutics Inc. (ATXI) Volatility At 8.60%, Should You Add A Position?

Avenue Therapeutics Inc. (NASDAQ: ATXI) is -89.28% lower on its value in year-to-date trading and has touched a low of $1.39 and a high of $26.85 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ATXI stock was last observed hovering at around $1.43 in the last trading session, with the day’s gains setting it 0.03%.

Currently trading at $1.46, the stock is -25.05% and -60.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.26 million and changing 2.10% at the moment leaves the stock -71.59% off its SMA200. ATXI registered -91.75% loss for a year compared to 6-month loss of -61.69%.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

The stock witnessed a -47.29% gain in the last 1 month and extending the period to 3 months gives it a -66.20%, and is -18.44% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.60% over the week and 13.02% over the month.

Distance from 52-week low is 5.07% and -94.56% from its 52-week high.

Avenue Therapeutics Inc. (ATXI) Analyst Forecasts

The EPS is expected to grow by 29.70% this year

Avenue Therapeutics Inc. (ATXI) Top Institutional Holders

The shares outstanding are 4.77M, and float is at 4.37M with Short Float at 4.86%.

Avenue Therapeutics Inc. (ATXI) Insider Activity

A total of 1 insider transactions have happened at Avenue Therapeutics Inc. (ATXI) in the last six months, with sales accounting for 1 and purchases happening 0 times. The most recent transaction is an insider sale by InvaGen Pharmaceuticals, Inc., the company’s 10% Owner. SEC filings show that InvaGen Pharmaceuticals, Inc. sold 388,888 shares of the company’s common stock on Oct 11 at a price of $7.71 per share for a total of $3.0 million. Following the sale, the insider now owns 0.0 shares.

Avenue Therapeutics Inc. (ATXI): Who are the competitors?

The company’s main competitors (and peers) include Omeros Corporation (OMER) that is -72.99% lower over the past 12 months.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell

 

 

100% Free. Stop Anytime. No Spam

111365

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.